Lung Cancer.pdf
Lung Cancer.pdf
Lung Cancer.pdf
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
204 R. Komaki<br />
tients (Pts) with limited disease (LD) small cell lung cancer (SCLC): preliminary<br />
results of RTOG 96–09 abstract. Proc Am Soc Clin Oncol 2000;19:490a.<br />
Feld R, Ginsberg RJ, Payne DG. Treatment of small cell lung cancer. In: Roth JA,<br />
Ruckdeschel JC, Weisenburger TH, eds. Thoracic Oncology. Philadelphia, PA:<br />
Saunders; 1993:229–262.<br />
Fox W, Scadding JG. Medical Research Council comparative trial of surgery and radiotherapy<br />
for primary treatment of small-celled or oat-celled carcinoma of<br />
bronchus. Ten-year follow-up. Lancet 1973;2(7820):63–65.<br />
Glisson B, Scott C, Komaki R, et al. Cisplatin, ifosfamide, oral etoposide, and concurrent<br />
accelerated hyperfractionated thoracic radiation for patients with limited<br />
small-cell lung carcinoma: results of Radiation Therapy Oncology Group trial<br />
93–12. J Clin Oncol 2000;18:2990–2995.<br />
Goto K, Nishiwaki Y, Takada M, et al. Final results of a phase III study of concurrent<br />
versus sequential thoracic radiotherapy (TRT) in combination with cisplatin<br />
(P) and etoposide (E) for limited-stage small cell lung cancer (LD-SCLC):<br />
the Japan Clinical Oncology Group (JCOG) study abstract. Proc Am Soc Clin Oncol<br />
1999;18:A1805. Abstract 468a.<br />
Greenlee RT, Hill-Harmon MB, Murray T, et al. <strong>Cancer</strong> statistics, 2001. CA <strong>Cancer</strong> J<br />
Clin 2001;51:15–36.<br />
Hainsworth JD, Gray JR, Stroup SL, et al. Paclitaxel, carboplatin, and extended-schedule<br />
etoposide in the treatment of small-cell lung cancer: comparison of sequential<br />
phase II trials using different dose-intensities. J Clin Oncol 1997;15:3464–3470.<br />
Janaki L, Rector D, Turrisi A, et al. Patterns of failure and second malignancies from<br />
SWOG-8629: concurrent cisplatin, etoposide, vincristine, and once daily radiotherapy<br />
for the treatment of limited small cell lung cancer abstract. Proc Am Soc<br />
Clin Oncol 1994;13:331.<br />
Johnson RE, Brereton HD, Kent CH. Small-cell carcinoma of the lung: attempt to<br />
remedy causes of past therapeutic failure. Lancet 1976;2(7980):289–291.<br />
Johnson BE, Bridges JD, Sobczeck M, et al. Patients with limited-stage small-cell<br />
lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin<br />
followed by cyclophosphamide, doxorubicin, and vincristine. J<br />
Clin Oncol 1996;14:806–813.<br />
Johnson BE, Salem C, Nesbitt J, et al. Limited stage small cell lung cancer treated<br />
with concurrent hyperfractionated chest radiotherapy and etoposide/cisplatin.<br />
<strong>Lung</strong> <strong>Cancer</strong> 1993;9(suppl 1):S21–S26.<br />
Kies MS, Mira JG, Crowley JJ, et al. Multimodal therapy for limited small-cell lung<br />
cancer: a randomized study of induction combination chemotherapy with or<br />
without thoracic radiation in complete responders; and with wide-field versus<br />
reduced-field radiation in partial responders: a Southwest Oncology Group<br />
study. J Clin Oncol 1987;5:592–600.<br />
Komaki R, Byhardt RW, Anderson T, et al. What is the lowest effective biologic dose<br />
for prophylactic cranial irradiation? Am J Clin Oncol 1985;8:523–527.<br />
Komaki R, Cox JD, Whitson W. Risk of brain metastasis from small cell carcinoma of<br />
the lung related to length of survival and prophylactic irradiation. <strong>Cancer</strong> Treatment<br />
Reports 1981;65:811–814.<br />
Komaki R, Meyers CA, Shin DM, et al. Evaluation of cognitive function in patients<br />
with limited small cell lung cancer prior to and shortly following prophylactic<br />
cranial irradiation. Int J Radiat Oncol Biol Phys 1995a;33:179–182.
Change language